Pharma Watch

Leading Pharma Leading Pharma

Challenged Pharma Challenged Pharma

FDA Approves Allergan’s Durysta Implant to Treat Glaucoma

FDA Approves Allergan’s Durysta Implant to Treat Glaucoma

Allergan announced the U.S. FDA has approved Durysta (bimatoprost implant) 10 mcg for intracameral administration. Durysta is the first intracameral, biodegradable sustained-release implant indicated to reduce intraocular pressure (IOP) in patients with open-angle...

FDA Places Clinical Hold on LogicBio’s Gene Therapy Treatment

FDA Places Clinical Hold on LogicBio’s Gene Therapy Treatment

LogicBio Therapeutics  announced that the U.S. FDA has placed a clinical hold on the Investigational New Drug (IND) submission for LB-001 for the treatment of methylmalonic acidemia (MMA) pending the resolution of certain clinical and nonclinical questions. LogicBio...

subscribe

subscribe
University at Buffalo
subscribe

Pin It on Pinterest